Clinical Trial Update: Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating inhaled pre-prandial human insulin for blood glucose control in type 2 diabetes; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled pre-prandial human insulin

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED